Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl G Nicholson

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Vaccine|March 18, 2003
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationIain Stephenson, Karl G Nicholson, Anthony Colegate, et al.
The Journal of Infection|August 10, 2014
Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sampleTristan W Clark, Marie-jo Medina, Sally Batham, et al.
BMJ (Clinical Research Ed.)|June 7, 2003
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsNicola J Cooper, Alexander J Sutton, Keith R Abrams, et al.
The European Respiratory Journal|September 5, 2014
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPDTristan W Clark, Marie-Jo Medina, Sally Batham, et al.
The New England Journal of Medicine|September 12, 2009
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccineTristan W Clark, Manish Pareek, Katja Hoschler, et al.
The Lancet. Infectious Diseases|October 17, 2008
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plansLance C Jennings, Arnold S Monto, Paul K S Chan, et al.
The Journal of Infection|September 13, 2016
Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illnessTristan W Clark, Sean Ewings, Marie-Jo Medina, et al.
Journal of Travel Medicine|November 14, 2008
Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCRPatrick T Kimmitt, Andrew Kirby, Nelun Perera, et al.
The Journal of Infectious Diseases|March 19, 2005
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategyIain Stephenson, Roberto Bugarini, Karl G Nicholson, et al.
The Journal of Infection|October 19, 2010
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic reviewRachel J Jackson, Katy L Cooper, Paul Tappenden, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Vaccine|March 18, 2003
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationIain Stephenson, Karl G Nicholson, Anthony Colegate, et al.
The Journal of Infection|August 10, 2014
Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sampleTristan W Clark, Marie-jo Medina, Sally Batham, et al.
BMJ (Clinical Research Ed.)|June 7, 2003
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsNicola J Cooper, Alexander J Sutton, Keith R Abrams, et al.
The European Respiratory Journal|September 5, 2014
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPDTristan W Clark, Marie-Jo Medina, Sally Batham, et al.
The New England Journal of Medicine|September 12, 2009
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccineTristan W Clark, Manish Pareek, Katja Hoschler, et al.
The Lancet. Infectious Diseases|October 17, 2008
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plansLance C Jennings, Arnold S Monto, Paul K S Chan, et al.
The Journal of Infection|September 13, 2016
Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illnessTristan W Clark, Sean Ewings, Marie-Jo Medina, et al.
Journal of Travel Medicine|November 14, 2008
Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCRPatrick T Kimmitt, Andrew Kirby, Nelun Perera, et al.
The Journal of Infectious Diseases|March 19, 2005
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategyIain Stephenson, Roberto Bugarini, Karl G Nicholson, et al.
The Journal of Infection|October 19, 2010
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic reviewRachel J Jackson, Katy L Cooper, Paul Tappenden, et al.
Pageof 5